CHCHD1

gene
On this page

Also known as FLJ25854mS37

Summary

CHCHD1 (coiled-coil-helix-coiled-coil-helix domain containing 1, HGNC:23518) is a protein-coding gene on chromosome 10q22.2, encoding Small ribosomal subunit protein mS37 (Q96BP2). It is a selective cancer dependency (DepMap: 70.9% of cell lines).

Enables RNA binding activity. Predicted to be involved in mitochondrial translation. Located in cytosol; mitochondrion; and nuclear lumen.

Source: NCBI Gene 118487 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 19 total
  • Cancer dependency (DepMap): dependent in 70.9% of screened cell lines
  • MANE Select transcript: NM_203298

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:23518
Approved symbolCHCHD1
Namecoiled-coil-helix-coiled-coil-helix domain containing 1
Location10q22.2
Locus typegene with protein product
StatusApproved
AliasesFLJ25854, mS37
Ensembl geneENSG00000172586
Ensembl biotypeprotein_coding
OMIM608842
Entrez118487

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000372833, ENST00000372837

RefSeq mRNA: 1 — MANE Select: NM_203298 NM_203298

CCDS: CCDS7334

Canonical transcript exons

ENST00000372833 — 3 exons

ExonStartEnd
ENSE000011841057378232373782441
ENSE000011841127378307473783652
ENSE000011841167378204873782199

Expression profiles

Bgee: expression breadth ubiquitous, 245 present calls, max score 95.97.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 59.3196 / max 441.0488, expressed in 1826 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
10554859.31961826

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499195.97gold quality
palpebral conjunctivaUBERON:000181295.18gold quality
right adrenal glandUBERON:000123394.76gold quality
right adrenal gland cortexUBERON:003582794.37gold quality
left adrenal glandUBERON:000123494.33gold quality
left adrenal gland cortexUBERON:003582594.24gold quality
oral cavityUBERON:000016793.97gold quality
ileal mucosaUBERON:000033193.68gold quality
mucosa of sigmoid colonUBERON:000499393.50gold quality
colonic mucosaUBERON:000031793.41gold quality
olfactory segment of nasal mucosaUBERON:000538693.31gold quality
hindlimb stylopod muscleUBERON:000425293.29gold quality
esophagus mucosaUBERON:000246993.28gold quality
esophagus squamous epitheliumUBERON:000692093.18gold quality
apex of heartUBERON:000209893.16gold quality
adult organismUBERON:000702393.09gold quality
lower esophagus mucosaUBERON:003583493.00gold quality
tibialis anteriorUBERON:000138592.96gold quality
metanephrosUBERON:000008192.95gold quality
biceps brachiiUBERON:000150792.92gold quality
gastrocnemiusUBERON:000138892.85gold quality
muscle of legUBERON:000138392.80gold quality
gingivaUBERON:000182892.74gold quality
gingival epitheliumUBERON:000194992.68gold quality
monocyteCL:000057692.67gold quality
corpus epididymisUBERON:000435992.64gold quality
leukocyteCL:000073892.62gold quality
adrenal cortexUBERON:000123592.58gold quality
parotid glandUBERON:000183192.58silver quality
heart left ventricleUBERON:000208492.46gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.80
E-MTAB-7606no560.86
E-MTAB-6524no339.38
E-MTAB-7303no148.92

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

24 targeting CHCHD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4533100.0069.482758
HSA-MIR-806899.9873.852376
HSA-MIR-205-3P99.9269.923165
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-498-5P99.7669.641807
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-5003-5P99.6169.131624
HSA-MIR-129099.5969.902079
HSA-MIR-315399.5567.592337
HSA-MIR-105-5P99.5469.242060
HSA-MIR-7853-5P99.5469.302055
HSA-MIR-4753-5P99.5468.511356
HSA-MIR-520E-5P99.2768.901513
HSA-MIR-6768-3P99.1467.381319
HSA-MIR-224-3P98.9168.421815
HSA-MIR-522-3P98.9168.561817
HSA-MIR-34C-3P98.1165.60858
HSA-MIR-6847-5P97.9366.741808
HSA-MIR-6781-3P97.4466.85970
HSA-MIR-148B-5P97.2966.30992
HSA-MIR-6874-3P97.2966.34975
HSA-MIR-2682-3P97.1066.16840
HSA-MIR-3152-5P96.9866.88819
HSA-MIR-616-3P96.8266.99784

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 70.9% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 2)

  • C2360, a nuclear protein expressed in cytotrophoblasts, is a representative member of a multifamily of proteins, sharing a protein domain that is conserved in eukaryotes. (PMID:15177562)
  • CHCHD1 mutations could not explain phenotype of patients with combined oxidative phosphorylation system deficiencies. (PMID:24137763)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriochchd1ENSDARG00000029100
mus_musculusChchd1ENSMUSG00000063787
rattus_norvegicusChchd1ENSRNOG00000009297
drosophila_melanogasterCG12848FBGN0040666
caenorhabditis_elegansWBGENE00016057

Protein

Protein identifiers

Small ribosomal subunit protein mS37Q96BP2 (reviewed: Q96BP2)

Alternative names: 28S ribosomal protein S37, mitochondrial, Coiled-coil-helix-coiled-coil-helix domain-containing protein 1, Nuclear protein C2360

All UniProt accessions (2): Q96BP2, A6NJX6

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.

Subcellular location. Mitochondrion. Nucleus.

Similarity. Belongs to the mitochondrion-specific ribosomal protein mS37 family.

RefSeq proteins (1): NP_976043* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR009069Cys_alpha_HP_mot_SFHomologous_superfamily
IPR010625CHCHDomain
IPR033620Ribosomal_mS37_metFamily

Pfam: PF06747

UniProt features (10 total): helix 3, short sequence motif 2, disulfide bond 2, chain 1, domain 1, turn 1

Structure

Experimental structures (PDB)

57 structures, top 30 by resolution.

PDBMethodResolution (Å)
7QI4ELECTRON MICROSCOPY2.21
7P2EELECTRON MICROSCOPY2.4
8RRIELECTRON MICROSCOPY2.4
9OLFELECTRON MICROSCOPY2.46
9OJMELECTRON MICROSCOPY2.5
6ZM6ELECTRON MICROSCOPY2.59
7QI5ELECTRON MICROSCOPY2.63
8ANYELECTRON MICROSCOPY2.85
6ZM5ELECTRON MICROSCOPY2.89
8K2AELECTRON MICROSCOPY2.9
9PGLELECTRON MICROSCOPY2.9
7PO1ELECTRON MICROSCOPY2.92
7PO3ELECTRON MICROSCOPY2.92
9PGFELECTRON MICROSCOPY2.93
6VMIELECTRON MICROSCOPY2.96
6RW4ELECTRON MICROSCOPY2.97
6VLZELECTRON MICROSCOPY2.97
7QI6ELECTRON MICROSCOPY2.98
8QRNELECTRON MICROSCOPY2.98
9PSMELECTRON MICROSCOPY2.98
8OISELECTRON MICROSCOPY3
9HFMELECTRON MICROSCOPY3
9UWHELECTRON MICROSCOPY3
9PGIELECTRON MICROSCOPY3.02
8QRMELECTRON MICROSCOPY3.05
9PG8ELECTRON MICROSCOPY3.06
9PS7ELECTRON MICROSCOPY3.08
7PO2ELECTRON MICROSCOPY3.09
8OIRELECTRON MICROSCOPY3.1
9HFOELECTRON MICROSCOPY3.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96BP2-F192.510.81

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (2): 45–76, 55–66

Function

Pathways and Gene Ontology

Reactome pathways

4 pathways

IDPathway
R-HSA-5368286Mitochondrial translation initiation
R-HSA-5389840Mitochondrial translation elongation
R-HSA-5419276Mitochondrial translation termination
R-HSA-9937383Mitochondrial ribosome-associated quality control

MSigDB gene sets: 95 (showing top): STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, WEI_MYCN_TARGETS_WITH_E_BOX, WTGAAAT_UNKNOWN, GOCC_MITOCHONDRIAL_ENVELOPE, BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, ACEVEDO_LIVER_CANCER_UP, GOCC_RIBOSOME, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE

GO Biological Process (1): mitochondrial translation (GO:0032543)

GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)

GO Cellular Component (10): fibrillar center (GO:0001650), nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), cytosol (GO:0005829), nucleus (GO:0005634), mitochondrial ribosome (GO:0005761), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Mitochondrial translation4

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cytoplasm2
intracellular membrane-bounded organelle2
mitochondrion1
translation1
mitochondrial gene expression1
nucleic acid binding1
binding1
nucleolus1
nuclear lumen1
organelle inner membrane1
mitochondrial membrane1
organellar small ribosomal subunit1
mitochondrial ribosome1
mitochondrial protein-containing complex1
organellar ribosome1
mitochondrial matrix1
intracellular membraneless organelle1
protein-containing complex1

Protein interactions and networks

STRING

2520 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CHCHD1MRPL47Q9HD33625
CHCHD1PTCD3Q96EY7604
CHCHD1A0A2R8YDH4A0A2R8YDH4580
CHCHD1MRPL42Q9Y6G3525
CHCHD1METTL17Q9H7H0519
CHCHD1RTP2Q5QGT7491
CHCHD1AURKAIP1Q9NWT8489
CHCHD1GADD45GIP1Q8TAE8479
CHCHD1TTLL1O95922473
CHCHD1MTG1Q9BT17463
CHCHD1ADAD1Q96M93458
CHCHD1FASTKD1Q53R41447
CHCHD1HTD2P86397446
CHCHD1OXA1LQ15070442
CHCHD1CPNE2Q96FN4419

IntAct

30 interactions, top by confidence:

ABTypeScore
CHCHD1SDCBP2psi-mi:“MI:0915”(physical association)0.560
MESDCHCHD1psi-mi:“MI:0915”(physical association)0.560
CHCHD1revpsi-mi:“MI:0915”(physical association)0.560
CBY1CFAP410psi-mi:“MI:0914”(association)0.510
revTMED10psi-mi:“MI:0914”(association)0.460
CHCHD1RCN2psi-mi:“MI:0914”(association)0.350
CHCHD1ALDH1L1psi-mi:“MI:0914”(association)0.350
MAPTSHTN1psi-mi:“MI:0914”(association)0.350
RBM39RPS3Apsi-mi:“MI:0914”(association)0.350
GTPBP10psi-mi:“MI:0914”(association)0.350
HNRNPDLpsi-mi:“MI:0914”(association)0.350
SUPT5Hpsi-mi:“MI:0914”(association)0.350
GTPBP1psi-mi:“MI:0914”(association)0.350
revMPGpsi-mi:“MI:0914”(association)0.350
EIF3Fpsi-mi:“MI:0914”(association)0.350
RPS10-NUDT3psi-mi:“MI:0914”(association)0.350
PHF20L1psi-mi:“MI:0914”(association)0.350
MRPL58psi-mi:“MI:0914”(association)0.350
MRPL18psi-mi:“MI:0915”(physical association)0.320
CHCHD1CBY1psi-mi:“MI:0915”(physical association)0.000
CHCHD1SDCBP2psi-mi:“MI:0915”(physical association)0.000
CHCHD1MESDpsi-mi:“MI:0915”(physical association)0.000

BioGRID (248): CHCHD1 (Affinity Capture-MS), PPM1K (Affinity Capture-MS), NRD1 (Affinity Capture-MS), IDE (Affinity Capture-MS), CHCHD4 (Affinity Capture-MS), PMPCA (Affinity Capture-MS), CBY1 (Affinity Capture-MS), CHCHD1 (Affinity Capture-MS), CHCHD1 (Affinity Capture-MS), CHCHD1 (Affinity Capture-MS), CHCHD1 (Two-hybrid), CHCHD1 (Two-hybrid), AATF (Proximity Label-MS), ACAD9 (Proximity Label-MS), ACOT1 (Proximity Label-MS)

ESM2 similar proteins: A1CH57, A5DUN2, A6ZMQ6, A9ULB4, B3LM82, B5RTE0, C8ZF59, G2TRP6, P00429, P0CM70, P0CM71, P0CM86, P0CM87, P0CT19, P21976, P56277, P90789, Q02373, Q05809, Q0P451, Q0UWF1, Q17Q91, Q1DJH5, Q208S3, Q2M2S5, Q2TAP8, Q3E7A9, Q3E846, Q462Q7, Q4IAJ1, Q4R374, Q53CG4, Q5B4S6, Q6C4R1, Q6CIT9, Q6DD38, Q6FQX5, Q6INR6, Q75D94, Q7S4H6

Diamond homologs: Q96BP2, Q9CQA6

SIGNOR signaling

1 interactions.

AEffectBMechanism
CHCHD1“form complex”“28S mitochondrial small ribosomal subunit”binding

Disease & clinical

Clinical variants and AI predictions

ClinVar

19 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance14
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

274 predictions. Top by Δscore:

VariantEffectΔscore
10:73782218:G:GTdonor_gain1.0000
10:73782233:G:GTdonor_gain1.0000
10:73782195:GGGCG:Gdonor_gain0.9900
10:73782196:GGCGG:Gdonor_gain0.9900
10:73782240:GAGCA:Gdonor_gain0.9900
10:73782474:A:Tdonor_gain0.9900
10:73782197:GCG:Gdonor_gain0.9800
10:73782239:G:GTdonor_gain0.9800
10:73782473:G:GTdonor_gain0.9800
10:73782196:GGCG:Gdonor_gain0.9700
10:73782197:GCGG:Gdonor_gain0.9700
10:73782233:G:Tdonor_gain0.9700
10:73782197:G:Tdonor_gain0.9600
10:73782200:G:GGdonor_gain0.9600
10:73782253:G:Tdonor_gain0.9500
10:73782321:A:AGacceptor_gain0.9500
10:73782322:G:Cacceptor_gain0.9500
10:73782322:G:GGacceptor_gain0.9500
10:73782242:GCA:Gdonor_gain0.9400
10:73782322:GAGGC:Gacceptor_gain0.9400
10:73782212:A:AGdonor_gain0.9300
10:73782213:G:GGdonor_gain0.9300
10:73782244:A:AGdonor_gain0.9300
10:73782437:CTCAG:Cdonor_loss0.9300
10:73782438:TCAGG:Tdonor_loss0.9300
10:73782439:CAG:Cdonor_loss0.9300
10:73782440:AG:Adonor_loss0.9300
10:73782441:GGT:Gdonor_loss0.9300
10:73782442:GTGAC:Gdonor_loss0.9300
10:73782443:T:Cdonor_loss0.9300

AlphaMissense

765 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:73782379:T:CF61L0.987
10:73782381:C:AF61L0.987
10:73782381:C:GF61L0.987
10:73782366:G:CW56C0.985
10:73782366:G:TW56C0.985
10:73782364:T:AW56R0.980
10:73782364:T:CW56R0.980
10:73782416:T:CF73S0.973
10:73782331:T:CC45R0.966
10:73782415:T:CF73L0.964
10:73782417:C:AF73L0.964
10:73782417:C:GF73L0.964
10:73782380:T:GF61C0.961
10:73782346:T:CS50P0.960
10:73782380:T:CF61S0.960
10:73782331:T:AC45S0.959
10:73782332:G:CC45S0.959
10:73782344:T:CM49T0.959
10:73782394:T:AC66S0.958
10:73782395:G:CC66S0.958
10:73782365:G:CW56S0.957
10:73783161:T:CF111L0.954
10:73783163:T:AF111L0.954
10:73783163:T:GF111L0.954
10:73782344:T:GM49R0.953
10:73782356:T:CM53T0.952
10:73782358:G:CA54P0.949
10:73782332:G:AC45Y0.948
10:73782395:G:AC66Y0.948
10:73782361:T:CC55R0.946

dbSNP variants (sampled 300 via entrez): RS1000729400 (10:73781508 A>G), RS1001097920 (10:73781165 A>G), RS1001631817 (10:73780309 TAAA>T,TA,TAA,TAAAA), RS1002900966 (10:73781832 G>A,C), RS1002922317 (10:73783478 G>A,C,T), RS1003492777 (10:73783719 G>A), RS1003715034 (10:73781865 C>A,G,T), RS1004549546 (10:73780701 C>T), RS1004582133 (10:73781020 G>A), RS1004980964 (10:73780239 G>T), RS1006148862 (10:73783823 G>T), RS1007822866 (10:73782104 T>G), RS1008158160 (10:73780741 G>C), RS1008943274 (10:73781017 C>T), RS1011029310 (10:73783610 C>T)

Disease associations

OMIM: gene MIM:608842 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST004132_74Crohn’s disease2.000000e-09
GCST007656_13Chronic obstructive pulmonary disease or resting heart rate (pleiotropy)2.000000e-10

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression, decreases expression3
bisphenol Aaffects expression, decreases expression2
Cyclosporinedecreases expression2
aristolochic acid Iincreases expression1
dicrotophosdecreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
potassium chromate(VI)affects cotreatment, decreases expression1
nivalenoldecreases expression1
epigallocatechin gallatedecreases expression, affects cotreatment1
di-n-butylphosphoric acidaffects expression1
2-palmitoylglycerolincreases expression1
K 7174decreases expression1
ICG 001decreases expression1
Resveratrolaffects cotreatment, increases expression1
Acetaminophendecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Benzo(a)pyreneincreases methylation1
Cadmiumincreases abundance, increases expression1
Plant Extractsaffects cotreatment, increases expression1
Smokedecreases expression1
Cadmium Chlorideincreases abundance, increases expression1
beta-Naphthoflavonedecreases expression1
Copper Sulfatedecreases expression1
Lactic Aciddecreases expression1
Genisteindecreases expression, increases reaction1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.